Australia: University of Sydney landmark investment to position city as leader in biomedical research

The University of Sydney is making its largest ever capital investment, a landmark A$478m (US$329m) to build a biomedical precinct to fast-track research and patient care in New South Wales. The Sydney Biomedical Accelerator (SBA) will create a first-in-Australia, 36,000 metres-squared health, education, and research precinct co-located at Royal Prince Alfred Hospital and the University’s Camperdown campuses,…

You must be a HMI Subscriber to view this content.

Subscribe Now »